Skip to main content
Log in

Surgical treatment for adult congenital heart disease: consideration for indications and procedures

  • Current Topics Review Article
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

The number of the adult patients with congenital heart diseases (ACHD) continues to grow owing to improvement of surgical results and medical management. Corrective surgery for complex CHD does not always mean complete cure. It is not rare that the patients will visit the cardiology institutes because of secondary lesions due to residua or sequela in adults. Some patients with CHD remain unrepairable with different degree of heart failure and pulmonary arterial hypertension. Association of arrhythmias is common in ACHD patients and sometimes critical. We experienced 265 surgical procedures for ACHD patients at our center between 1999 and 2015. Of these procedures, palliative surgery was performed in 3%, palliation to corrective surgery in 6%, primary repair in 57%, and redo surgery in 34%. Hospital mortality within 30 days in this period was 1.1%. Surgery for ACHD patients is safe, beneficial and low-risk treatment; however, tailored procedures for the individual patient are essential to obtain the optimal quality. A comprehensive multidisciplinary approach is required to fulfill this goal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Srinathan SK, Bonser RS, Thorne SA, et al. Changing practice of cardiac surgery in adult patients with congenital heart disease. Heart. 2004;91:207–12.

    Article  Google Scholar 

  2. Niwa K, Akagi T, Ichikawa H, et al. Guidelines for management of congenital heart disease in adults (2011 revised edition). JCS. 2011; 1–135.

  3. Shina Y, Toyoda T, Kawasoe Y, et al. Prevalence of adult patients with congenital heart disease in Japan. Int J Cardiol. 2011;146:13–6.

    Article  Google Scholar 

  4. Walsh EP, Cecchin F. Arrhythmias in adult patients with congenital heart disease. Circulation. 2007;115:534–45.

    Article  PubMed  Google Scholar 

  5. Ochiai R, Yao A, Kinugawa K, et al. Status and future needs of regional adult congenital heart disease centers in Japan. Circ J. 2011;75:2220–7.

    Article  PubMed  Google Scholar 

  6. Filippov AA, Del Nido PJ, Vasilyev NV. Management of systemic right ventricular failure in patients with congenitally corrected transposition of the great arteries. Circulation. 2016;134(17):1293 – 302.

    Article  PubMed  Google Scholar 

  7. Perloff JK. Surgical closure of atrial septal defect in adults. N Engl J Med. 1995;333:513–4.

    Article  CAS  PubMed  Google Scholar 

  8. Giamberti A, Chessa M, Foresti S, et al. Combined atrial septal defect surgical closure and irrigated radiofrequency ablation in adult patients. Ann Thorac Surg. 2006;82:1327–31.

    Article  PubMed  Google Scholar 

  9. Nitta T, Sakamoto S. Miyagi Y, et al. Reentrant and focal activations during atrial fibrillation in patients with atrial septal defect. Ann Thorac Surg. 2013;96(4):1266–72.

    Article  PubMed  Google Scholar 

  10. Wi J, Choi JY, Shim JM, Uhm JS, et al. Fate of preoperative atrial fibrillation after correction of atrial septal defect. Circ J. 2013;77(1):109 – 15.

    Article  PubMed  Google Scholar 

  11. Galie N, Beghetti M, Gatzoulis MA, et al. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, pracebo-controlled study. Circulation. 2006;114:48–54.

    Article  CAS  PubMed  Google Scholar 

  12. Singh TP, Rohit M, Grover A, et al. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension. Am Heart J. 2006;151(4):851 e1–5.

    Article  Google Scholar 

  13. Fernandes SM, Newburger JW, Lang P, et al. Usefulness of epoprostenol therapy in the severity ill adolescent/adult with Eisenmenger physiology. Am J Cardiol. 2003;91:632–5.

    Article  CAS  PubMed  Google Scholar 

  14. Galie N, Palazzini M, Manes A. Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. Eur Heart J. 2010;31(17):2080–6.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Baumgartner H, Bonhoeffer P, De Groot NMS, et al. WSC guidelines for the management of grown-up congenital heart disease. Eur Heart J. 2010;31:2915–2957.

    Google Scholar 

  16. Dimopoulos K, Peset A, Gatzoulis MA. Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy. Int J Cardiol. 2008;129(2):163–71.

    Article  PubMed  Google Scholar 

  17. Schwerzmann M, Zafar M, McLaughlin PR, et al. Atrial septal defect closure in a patient with “irreversible” pulmonary hypertensive arteriopathy. Int J Cardiol. 2006;110(1):104–7.

    Article  PubMed  Google Scholar 

  18. Benson LN, Child JS, Schwaiger M, Perloff JK, Schelbert HR. Left ventricular geometry and function in adults with Ebstein’s anomaly of the tricuspid valve. Circulation. 1987;75:353–9.

    Article  CAS  PubMed  Google Scholar 

  19. Carpentier A, Chauvaud S, Mace L, et al. A new reconstructive operation for Ebstein’s anomaly of the tricuspid valve. J Thorac Cardiovasc Surg. 1988;96(1):92–101.

    CAS  PubMed  Google Scholar 

  20. Dearani JA, Danielson GK. Surgical management of Ebstein’s anomaly in the adult. Semin Thorac Cardiovasc Surg. 2005;17(2):148 – 54.

    Article  PubMed  Google Scholar 

  21. Hetzer R, Negdyman N, Ewert P, et al. A modified repair technique for tricuspid incompetence in Ebstein’s anomaly. J Thorac Cardiovasc Surg. 1998;115:857–68.

    Article  CAS  PubMed  Google Scholar 

  22. da Silva JP, Baumgratz JF, et al. The cone reconstruction of the tricuspid valve in Ebstein’s anomaly. The operation: early and midterm results. J Thorac Cardiovasc Surg. 2007;133:215–23.

    Article  PubMed  Google Scholar 

  23. Brown ML, Dearani JA, Danielson GK, et al. Comparison of the outcome of porcine bioprosthetic versus mechanical prosthetic replacement of the tricuspid valve in the Ebstein anomaly. Am J Cardiol. 2009;103(4):555 – 61.

    Article  PubMed  Google Scholar 

  24. Baudiu CC, Schriber C, et al. Early timing of surgical intervention in patients with Ebstein’s anomaly predicts superior long-term outcome. Eur J Cardiothorac Surg. 2010;37:186–92.

    Article  Google Scholar 

  25. Brown ML, Dearani JA, et al. The outcomes of operations for 539 patients with Ebstein anomaly. J Thorac Cardiovasc Surg. 2008;135:1120–36.

    Article  PubMed  Google Scholar 

  26. Graham TP Jr, Bernard YD, Mellen BG, et al. Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol. 2000;36(1):255 – 61.

    Article  PubMed  Google Scholar 

  27. Hraska V, Duncan BW, Mayer JE Jr, et al. Long-term outcome of surgically treated patients with corrected transposition of the great arteries. J Thorac Cardiovasc Surg. 2005;129(1):182 – 91.

    Article  PubMed  Google Scholar 

  28. Mongeon FP, Connolly HM, Derabi JA. Congenitally corrected transposition of the great arteries ventricular function at the time of systemic atrioventricular valve replacement predicts long-term ventricular function. J Am Coll Cardiol. 2011;57:2008–17.

    Article  Google Scholar 

  29. Scherptong RW, Vliegen HW, Winter MM, et al. Tricuspid valve surgery in adults with a dysfunctional systemic right ventricle: repair or replace? Circulation. 2009;119(11):1467–72.

    Article  PubMed  Google Scholar 

  30. Ilbawi MN, DeLeon SY, Backer CL, et al. An alternative approach to the surgical management of physiologically corrected transposition with ventricular septal defect and pulmonary stenosis or atresia. J Thorac Cardiovasc Surg. 1990;100(3):410–5.

    CAS  PubMed  Google Scholar 

  31. Duncan BW, Mee RB. Management of the failing systemic right ventricle. Semin Thorac Cardiovasc Surg. 2005;17(2):160–9.

    Article  PubMed  Google Scholar 

  32. Roubertie F, Peltan J, Henaine R, et al. Early to midterm results of total cavopulmonary connection in adult patients. Ann Thorac Surg. 2013;95(3):941–7.

    Article  PubMed  Google Scholar 

  33. Burkhart HM, Dearani JA, et al. The modified Fontan procedure: early and late results in 132 adult patients. J Thorac Cardiovasc Surg. 2003;125:1252–9.

    Article  PubMed  Google Scholar 

  34. Sughimoto K, Matsuo K, Niwa K, et al. Fontan completions over 10 years after Glenn procedures. Cardiol Young. 2014;24(2):290–6.

    Article  PubMed  Google Scholar 

  35. Oechslin E. Hematological management of the cyanotic adult with congenital heart disease. Int J Cardiol. 2004;97 Suppl 1:109 – 15.

  36. Perrier S, Gerelli S, Hoang Minh T, Billaud P, et al. Concomitant repair of tetralogy of Fallot and an aortic root aneurysm in an adult. J Card Surg. 2017;32(1):57 – 9.

    Article  PubMed  Google Scholar 

  37. Erdogan HB, Bozbuga N, Kayalar N, Erentug V, Omeroglu SN, Kirali K, et al. Long-term outcome after total correction of tetralogy of Fallot in adolescent and adult age. J Card Surg. 2005;20(2):119–23.

    Article  PubMed  Google Scholar 

  38. Mizuno A, Niwa K, Matsuo K, et al. Survey of reoperation indications in tetralogy of fallot in Japan. Circ J. 2013;77(12):2942–7.

    Article  PubMed  Google Scholar 

  39. Gatzouli MA, Baraji S, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356:975–81.

    Article  Google Scholar 

  40. Geva T. Indication and timing of pulmonary valve replacement after tetralogy of Fallot repair. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 11–22: 2006.

  41. Therrien J, Provost Y, Merchant N, et al. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol. 2005;95:779–82.

    Article  PubMed  Google Scholar 

  42. Scherptong RW, Hazekamp MG, Mulder BJ, et al. Follow-up after pulmonary valve replacement in adults with tetralogy of Fallot: association between QRS duration and outcome. J Am Coll Cardiol. 2010;56:1486–92.

    Article  PubMed  Google Scholar 

  43. Hirose N, Matsuo K, Kabasawa M, et al. The mid-term effects of pulmonary valve replacement on right ventricular function in adult patients with tetralogy of Fallot. J Adult Congenit Heart Dis. 2013;2:22–8.

    Google Scholar 

  44. Burchill LJ, Wald RM, Harris L, Colman JM, Silversides CK. Pulmonary valve replacement in adults with repaired tetralogy of Fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2011;14(1):92–7.

    Article  PubMed  Google Scholar 

  45. Sabate Rotes A, Eidem BW, Connolly HM, et al. Long-term follow-up after pulmonary valve replacement in repaired tetralogy of Fallot. Am J Cardiol. 2014;114(6):901–8.

    Article  PubMed  Google Scholar 

  46. Gelatt M, Hamilton RM, McCrindle BW, Gow RM, Williams WG, Trusler GA, et al. Risk factors for atrial tachyarrhythmias after the Fontan operation. J Am Coll Cardiol. 1994;24(7):1735–41.

    Article  CAS  PubMed  Google Scholar 

  47. Mavroudis C, Backer CL, Deal BJ, Johnsrude C, Strasburger J. Total cavopulmonary conversion and maze procedure for patients with failure of the Fontan operation. J Thorac Cardiovasc Surg. 2001;122(5):863–71.

    Article  CAS  PubMed  Google Scholar 

  48. Backer CL. 12th Annual C. Walton Lillehei memorial lecture in cardiovascular surgery: Fontan conversion–the Chicago experience. Cardiol Young. 2011;21:169–76.

    Article  PubMed  Google Scholar 

  49. Hiramatsu T, Iwata Y, Matsumura G, Konuma T, Yamazaki K. Impact of Fontan conversion with arrhythmia surgery and pacemaker therapy. Eur J Cardiothorac Surg. 2011;40(4):1007–10.

    PubMed  Google Scholar 

  50. Sridhar A, Giamberti A, Foresti S, Cappato R, Garcia CR, Cabrera ND, et al. Fontan conversion with concomitant arrhythmia surgery for the failing atriopulmonary connections: mid-term results from a single centre. Cardiol Young. 2011;21(6):665–9.

    Article  PubMed  Google Scholar 

  51. Brown ML, Dearani JA, Burkhart HM. The adult with congenital heart disease: medical and surgical considerations for management. Curr Opin Pediatr. 2009;21(5):561–4.

    Article  PubMed  Google Scholar 

  52. Srinathan SK, Bonser RS, Sethia B, Thorne SA, Brawn WJ, Barron DJ. Changing practice of cardiac surgery in adult patients with congenital heart disease. Heart. 2005;91(2):207–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Stellin G, Vida VL, Padalino MA, Rizzoli G, European Congenital Heart Surgeons A. Surgical outcome for congenital heart malformations in the adult age: a multicentric European study. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2004;7:95–101.

    Article  CAS  PubMed  Google Scholar 

  54. Vouhe P. Surgery for congenital heart disease in the adult: characteristics. Arch Mal Coeur Vaiss. 2002;95(11):1023–6.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kozo Matsuo.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matsuo, K., Kabasawa, M., Asano, S. et al. Surgical treatment for adult congenital heart disease: consideration for indications and procedures. Gen Thorac Cardiovasc Surg 66, 57–64 (2018). https://doi.org/10.1007/s11748-017-0861-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-017-0861-2

Keywords

Navigation